U.S. market Closed. Opens in 6 hours 41 minutes

FIXX | Homology Medicines, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue1.16M3.21M33.97M2.70M1.67M3.68MN/AN/A
Cost of Revenue578.00K2.60M9.54M100.39M89.40MN/AN/AN/A
Gross Profit578.00K609.00K24.43M-97.69M-87.73M3.68MN/AN/A
Operating Expenses92.68M136.49M129.92M132.97M111.61M65.25M29.66MN/A
Selling, General & Admin30.68M38.14M36.84M32.57M22.21M17.30M8.28M4.31M
Research & Development62.00M98.35M93.08M100.39M89.40M47.95M21.38M5.69M
Other Operating Expenses9.33MN/AN/AN/AN/AN/AN/AN/A
Operating Income-92.10M-133.28M-95.95M-130.26M-109.94M-61.56M-29.66M-10.00M
Other Expenses / Income5.02M134.48M185.00K1.57M6.03M4.35M-333.37K1.95M
Before Tax Income-87.08M1.20M-95.76M-128.69M-103.92M-57.22M-29.99M-8.05M
Income Tax Expenses25.88M715.00K-185.00K-1.57M-6.03M4.35MN/AN/A
Net Income-112.96M483.00K-95.58M-127.12M-97.89M-57.22M-29.99M-8.05M
Interest ExpensesN/A-260.24MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding321.30K318.89K307.13K255.06K233.99K28.55M18.60M18.60M
Diluted Shares Outstanding321.30K318.89K307.13K255.06K233.99K28.55M18.60M18.60M
EBITDA-91.52M-263.24M-87.60M-122.30M-103.62M-60.27M-29.31M-9.76M
EBITDA Margin-7,917.30%-8,205.64%-257.86%-4,526.20%-6,219.99%-1,636.13%0.00%0.00%
EBIT-87.08M-259.04M-95.76M-128.69M-103.92M-52.87M-29.99M-8.05M
EBIT Margin-7,532.87%-8,074.88%-281.90%-4,762.92%-6,237.45%-1,435.02%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙